PLASMA AND SYNOVIAL-FLUID INTERLEUKIN-1, INTERLEUKIN-6 AND SUBSTANCE-P CONCENTRATIONS IN RHEUMATOID-ARTHRITIS PATIENTS - EFFECT OF THE NONSTEROIDAL ANTIINFLAMMATORY DRUGS INDOMETHACIN, DICLOFENAC AND NAPROXEN
P. Sacerdote et al., PLASMA AND SYNOVIAL-FLUID INTERLEUKIN-1, INTERLEUKIN-6 AND SUBSTANCE-P CONCENTRATIONS IN RHEUMATOID-ARTHRITIS PATIENTS - EFFECT OF THE NONSTEROIDAL ANTIINFLAMMATORY DRUGS INDOMETHACIN, DICLOFENAC AND NAPROXEN, Inflammation research, 44(11), 1995, pp. 486-490
We performed an open, between patients, placebo controlled study in or
der to evaluate the effect of the treatment with the non steroidal ant
i inflammatory drugs indomethacin, diclofenac and naproxen on the conc
entrations of the cytokines IL-1 beta and IL-6 and of the neuropeptide
substance P in plasma and synovial fluid of 24 rheumatoid arthritis p
atients. All patients had high synovial fluid cytokine and substance P
levels, and high plasma cytokine levels at the beginning of the study
. The treatment with the non steroidal anti inflammatory drugs signifi
cantly decreased both plasma and synovial fluid IL-6 and synovial flui
d substance P in comparison to placebo, but did not affect IL-1 beta c
oncentrations. This effect can participate in the therapeutic effect o
f non steroidal anti inflammatory drugs in rheumatoid arthritis.